Description

SUPHACID SUSPENSION 1020 MG

Indications

SUPHACID SUSPENSION 1020 MG is primarily indicated for the treatment of conditions associated with excessive gastric acidity. This includes but is not limited to gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia. The suspension provides symptomatic relief from heartburn and acid indigestion, making it a valuable option for patients experiencing discomfort due to high acid levels in the stomach.

Mechanism of Action

SUPHACID SUSPENSION 1020 MG contains active ingredients that work by neutralizing gastric acid. The primary mechanism involves the formation of a protective barrier over the gastric mucosa, which helps to reduce irritation caused by acid. By increasing the pH level in the stomach, the suspension effectively alleviates the symptoms associated with acid-related disorders. Additionally, it may promote healing of the gastric lining, further contributing to its therapeutic effects.

Pharmacological Properties

SUPHACID SUSPENSION 1020 MG exhibits antacid properties, which are crucial in its role as a treatment for acid-related conditions. The pharmacokinetics of the active ingredients indicate rapid absorption and onset of action, typically within minutes after administration. The suspension form allows for easy administration and improved patient compliance. Furthermore, the formulation is designed to provide prolonged acid neutralization, offering extended relief from symptoms.

Contraindications

SUPHACID SUSPENSION 1020 MG is contraindicated in patients with known hypersensitivity to any of its components. Additionally, it should not be used in individuals with severe renal impairment or those who are on a sodium-restricted diet, as the formulation may contain sodium bicarbonate. Caution is advised in patients with a history of gastrointestinal obstruction or those with chronic kidney disease, as the use of antacids may exacerbate these conditions.

Side Effects

Common side effects associated with the use of SUPHACID SUSPENSION 1020 MG may include gastrointestinal disturbances such as nausea, constipation, or diarrhea. In rare instances, patients may experience allergic reactions, which could manifest as rash, itching, or swelling. Long-term use of antacids may lead to metabolic alkalosis, particularly in patients with pre-existing conditions affecting acid-base balance. It is essential for patients to report any unusual or severe side effects to their healthcare provider.

Dosage and Administration

The recommended dosage of SUPHACID SUSPENSION 1020 MG varies depending on the severity of symptoms and the patient’s age. For adults, the typical dose is 10-20 mL taken after meals and at bedtime, not exceeding the maximum daily limit as prescribed by a healthcare professional. For children, the dosage should be determined by a pediatrician based on the child’s weight and age. It is important to shake the suspension well before use to ensure uniform distribution of the active ingredients.

Interactions

SUPHACID SUSPENSION 1020 MG may interact with certain medications, potentially altering their effectiveness. Antacids can affect the absorption of drugs such as tetracyclines, quinolone antibiotics, and iron supplements. It is advisable to separate the administration of these medications by at least two hours to minimize interaction risks. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements, to ensure safe and effective use of SUPHACID SUSPENSION.

Precautions

Patients should use SUPHACID SUSPENSION 1020 MG with caution if they have a history of kidney disease, heart disease, or hypertension. Regular monitoring of electrolyte levels may be necessary for patients on long-term therapy. Pregnant and breastfeeding women should consult their healthcare provider before using this medication, as the effects on fetal and neonatal health are not fully established. It is also important for patients to follow dietary recommendations to manage acid levels effectively while using this suspension.

Clinical Studies

Clinical studies have demonstrated the efficacy of SUPHACID SUSPENSION 1020 MG in reducing symptoms of acid-related disorders. In a randomized controlled trial, patients receiving the suspension reported significant improvement in heartburn and overall quality of life compared to those receiving a placebo. The safety profile of the suspension was also assessed, revealing that most side effects were mild and transient. Long-term studies are ongoing to further evaluate the benefits and risks associated with prolonged use of this antacid formulation.

Conclusion

SUPHACID SUSPENSION 1020 MG is a well-established antacid formulation that provides effective relief from symptoms associated with excessive gastric acidity. Its mechanism of action, pharmacological properties, and favorable safety profile make it a valuable option for patients suffering from acid-related conditions. However, it is essential for patients to use this medication responsibly, adhere to prescribed dosages, and consult healthcare providers regarding any potential interactions or side effects. With proper use, SUPHACID SUSPENSION can significantly enhance the quality of life for individuals dealing with gastric acidity issues.